Atlas Trials

Macrophage Activation Syndrome

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Macrophage Activation Syndrome

RecordFirmDate
Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome (NCT05137496)Beijing Friendship Hospital2022-06-01
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction (NCT04339712)Hellenic Institute for the Study of Sepsis2020-04-02
Characterization of the Inflammatory Profile of Patients With Macrophage Activation Syndrome Secondary to Bacterial Sepsis (NCT03721809)University Hospital, Rouen2019-03-21
Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer (NCT03827343)National Cancer Institute (NCI)2019-01-23
A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH) (NCT03311854)Swedish Orphan Biovitrum2018-02-20
Treatment of Macrophage Activation Syndrome (MAS) With Anakinra (NCT02780583)University of Alabama at Birmingham2016-05-15
Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome（MAS） (NCT02569463)Peking University People's Hospital2014-06-01
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation (NCT01966367)Diane George2013-03-01
New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome (NCT01095146)Amrita Institute of Medical Sciences & Research Center2010-03-01

Track Macrophage Activation Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.